Article

Respiratory syncytial virus vaccine mRNA lipid nanoparticles pattern determined via bioinformatics

2024-05-27

Abstract excerpt

<h4>Background: </h4> RSV, or respiratory syncytial virus , is a deadly condition that is present all over the world today. Without systemic transmission, the infection is initially contained to the lower respiratory tract. The objective of the study: Bioinformatics was used in Egypt to create an mRNA vaccine against the Respiratory syncytial virus (RSV) . <h4>Method: </h4> ology: In the present screening expe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a56dabf-d254-599e-9bed-932092882b42
DOI: 10.22541/au.171680806.69967670/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Respiratory syncytial virus vaccine mRNA lipid nanoparticles pattern determined via bioinformaticsDOI 10.22541/au.171680806.69967670/v1Read

<em>Respiratory Syncytial Virus</em> Vaccine mRNA Lipid Nanoparticles Pattern Determined via BioinformaticsSemantic proximity Read

Design of Lipid Nanoparticles of mRNA Vaccine against Respiratory Syncytial Virus by Bioinformatics in EgyptSemantic proximity Read

Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial VirusSemantic proximity Read

Formulation and Evaluation of Bivalent Swine and Avian Lipid Nanoparticles mRNA VaccineSemantic proximity Read

A new vaccine strategy based on VLSs for use against SARS-CoV-2 variants: Evaluation of their immune effectiveness and investigation of the mechanismSemantic proximity Read

Harnessing Computational Strategies to Overcome Challenges in mRNA VaccinesSemantic proximity Read

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read

The Preclinical Evaluation of Self-Replicating RNA Oral Vaccine to Simultaneously Neutralize Both SARS-CoV-2 Delta and Alpha VariantsSemantic proximity Read

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine DevelopmentSemantic proximity Read

Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studiesSemantic proximity Read

Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Semantic proximity Read

Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particlesSemantic proximity Read